IL37 and irritable bowel syndrome: As more evidence emerges demonstrating the harmful function of the IL-23/Th17 axis in IBD (239, 240), it seems to be evident that suppressing the microbial determinants leading to this detrimental inflammatory reaction in DCs whereas reestablishing the eubiotic structure of the gut microbiota might be an appealing therapeutic approach for IBD (241).